Browse result page of CPPsite 2.0
The total number entries retrieved from this search are 446| ID | PEPTIDE SEQUENCE | PEPTIDE NAME | LENGTH | CHIRALITY | LINEAR/CYCLIC | SOURCE | CATEGORY | N TERMINAL MODIFICATION | C TERMINAL MODIFICATION | CHEMICAL MODIFICATION | CARGO | PUBMED ID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2605 | RXRXRXRXRXRXRXRXB | (RX)8B | 17 | Modified | Linear | Synthetic | Cationic | NA | NA | X, 6-aminohexanoic acid (Ahx) and B, Beta-Alanine | Nucleic acid [PPMOs targeting translation initiation site of p53 mRNA (M1)] | 21765469 |
| 2606 | RXRXRXRXRXRXRXRXB | (RX)8B | 17 | Modified | Linear | Synthetic | Cationic | NA | NA | X, 6-aminohexanoic acid (Ahx) and B, Beta-Alanine | Nucleic acid [PPMOs targeting splice acceptor site of exon 10 (E10SA)] | 21765469 |
| 2607 | RXRXRXRXRXRXRXRXB | (RX)8B | 17 | Modified | Linear | Synthetic | Cationic | NA | NA | X, 6-aminohexanoic acid (Ahx) and B, Beta-Alanine | Nucleic acid [PPMOs targeting the coding region within exon 10 | 21765469 |
| 2613 | LLIILRRRIRKQAHAHSK | pVEC | 18 | L | Linear | Protein derived | Amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 21996011 |
| 2614 | LLIILRRRIRRRARARSR | P9R | 18 | L | Linear | Synthetic | Amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 21996011 |
| 2615 | LLHILRRSIRKQAHAIRK | S6KR | 18 | L | Linear | Synthetic | Amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 21996011 |
| 2616 | LLRILRRSIRRARRAIRR | S9R | 18 | L | Linear | Synthetic | Amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 21996011 |
| 2617 | LLHILRRSIRRQAHAIRR | S6R | 18 | L | Linear | Synthetic | Amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 21996011 |
| 2618 | LLRHLRRHIRRARRHIRR | S9RH | 18 | L | Linear | Synthetic | Amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 21996011 |
| 2623 | CGRKKRWWRQRRRPPQ | II | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2624 | CGRKKRRQRRWWRPPQ | III | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2625 | CGRKKRRQRWWRRPPQ | IV | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2626 | CGRKKRWWRQRWWRWWRPPQ | V | 20 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2627 | CGRKKRAARQRRRPPQ | VI | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2628 | CGRKKRRQRRAARPPQ | VII | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2629 | CGRKKRRQRAARRPPQ | VIII | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2630 | CGRKKRAARQRAARAARPPQ | IX | 20 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2631 | CGRKKRLLRQRRRPPQ | X | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2632 | CGRKKRRQRRLLRPPQ | XI | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2633 | CGRKKRRQRLLRRPPQ | XII | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2634 | CGRKKRLLRQRLLRLLRPPQ | XIII | 20 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Fluorescein) | 22100438 |
| 2652 | KLALKLALKALKAALKLA | Cyt c-ss-MAP | 18 | L | Linear | Synthetic | Amphipathic | Conjugated to Radiolabeled cytochrome c with disulphide linkage | NA | NA | Protein (Cyt C protein) | 22225540 |
| 2657 | FXrFXrFXrFXrFXrFXr | (Fxr)6 | 18 | Modified | Linear | Synthetic | Cationic | NA | NA | Fx, cyclohexylalanine | Fluorophore (Fluorescein) | 22238158 |
| 2660 | RQIKIWFQNRRMKWKK | Penetratin | 16 | L | Linear | Protein derived | Cationic and amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 22281502 |
| 2661 | RQIKIWFQNRRMKWKKC | Pen-Cys | 17 | L | Linear | Protein derived | Cationic and amphipathic | NA | NA | Cysteine modification | Nucleic acid (Plasmid DNA) | 22281502 |
| 2662 | RQIRIWFQNRRMRWRR | PenArg | 16 | L | Linear | Synthetic | Cationic and amphipathic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 22281502 |
| 2663 | RQIRIWFQNRRMRWRRC | PenArg-Cys | 17 | L | Linear | Synthetic | NA | NA | NA | Cysteine modification | Nucleic acid (Plasmid DNA) | 22281502 |
| 2667 | RQIKIWFQNRRMKWKKGC | Pen | 18 | L | Linear | Synthetic | Cationic | NA | Amidation | NA | Fluorophore (Alexa660) | 22285548 |
| 2671 | RRRRRRRRRRRRRRRRGC | R16 | 18 | L | Linear | Synthetic | Cationic | NA | Amidation | NA | Fluorophore (Alexa660) | 22285548 |
| 2690 | FFLIPKGRRRRRRRRGC | PasR8 (Alexa) | 17 | L | Linear | Synthetic | Cationic | NA | Amidation | NA | Fluorophore (Alexa) | 22486588 |
| 2694 | FFFFFFGRRRRRRRRGC | F6R8 (Alexa) | 17 | L | Linear | Synthetic | Cationic | NA | Amidation | NA | Fluorophore (Alexa) | 22486588 |
| 2703 | FFLIPKGRRRRRRRRGC | PasR8-p27kip1C | 17 | L | Linear | Synthetic | Cationic | NA | Amidation | NA | Peptide (cyclin-dependent kinase inhibitor) | 22486588 |
| 2706 | FFLIPKGRRRRRRRRGC | PasR8-PAD | 17 | L | Linear | Synthetic | Cationic | NA | Amidation | NA | Peptide [(Proapoptotic domain (PAD)] | 22486588 |
| 2712 | GCGGGYGRKKRRQRRR | Tat | 16 | L | Linear | Protein derived | Cationic | NA | NA | NA | Nanoparticle | 22531849 |
| 2717 | FFLIPKGRRRRRRRRR | PR9 | 16 | L | Linear | Synthetic | Cationic | NA | NA | NA | Nucleic acid (Plasmid DNA) | 22669044 |
| 2757 | RQIKIWFQNRRMKWKK | penetratin | 16 | L | Linear | Protein derived | Cationic and amphipathic | NA | NA | PEGylation | Nanoparticle (PEG-PLA) | 22841849 |
| 2764 | RLLRLLLRLWRRLLRLLR | C6 | 18 | L | Linear | Synthetic | Amphipathic | Acetylation | Amidation | NA | Nucleic acid (siRNA) | 23077976 |
| 2767 | YGRKKRRQRRR-acp-ENAEYLR | Tat-ENAEYLR | 19 | Modified | Linear | Synthetic | Cationic | Free | Amidation | acp, Epsilon-aminocaproic acid | Fluorophore (FITC) | 23085023 |
| 2768 | YGRKKRRQRRR-acp-QNAQYLR | Tat-QNAQYLR | 19 | Modified | Linear | Synthetic | Cationic | Free | Amidation | acp, Epsilon-aminocaproic acid | Fluorophore (FITC) | 23085023 |
| 2769 | YGRKKRRQRRR-acp-DYQQD | Tat-DYQQD | 17 | Modified | Linear | Synthetic | Cationic | Free | Amidation | acp, Epsilon-aminocaproic acid | Fluorophore (FITC) | 23085023 |
| 2770 | YGRKKRRQRRR-acp-NYQQN | Tat-NYQQN | 17 | Modified | Linear | Synthetic | Cationic | Free | Amidation | acp, Epsilon-aminocaproic acid | Fluorophore (FITC) | 23085023 |
| 2772 | RQIKIWFQNRRMKWKK | Penetratin | 16 | L | Linear | Protein derived | Cationic and amphipathic | Free | Free | NA | Protein (Single-Chain Antibody) | 23160949 |
| 2773 | CALNN-YGRKKRRQRRR | Tat | 16 | L | Linear | Protein derived | Cationic | Free | Free | NA | Nanoparticle (Quantum dots) | 23184894 |
| 2777 | RLLRLLRRLLRLLRRLLRC | PL | 19 | L | Linear | Synthetic | NA | Free | Free | NA | Nanoparticle (siRNA loaded liposmes) | 23384441 |
| 2778 | RGDRGDRRDLRLDRGDLRC | PD1 | 19 | L | Linear | Synthetic | NA | Free | Free | NA | Nanoparticle (siRNA loaded liposmes) | 23384441 |
| 2779 | RGDRLDRRDLRLDRRDLRC | PD2 | 19 | L | Linear | Synthetic | NA | Free | Free | NA | Nanoparticle (siRNA loaded liposmes) | 23384441 |
| 2780 | RGERGERRELRLERGELRC | PE1 | 19 | L | Linear | Synthetic | NA | Free | Free | NA | Nanoparticle (siRNA loaded liposmes) | 23384441 |
| 2781 | RGERLERRELRLERRELRC | PE2 | 19 | L | Linear | Synthetic | NA | Free | Free | NA | Nanoparticle (siRNA loaded liposmes) | 23384441 |
| 2785 | GGGRRRRRRYGRKKRRQRR | G3R6TAT | 19 | L | Linear | Synthetic | Cationic | Free | Free | NA | Nanoparticle (Silver) | 23525222 |
| 2790 | GLKKLAELFHKLLKLG | TAMARA-peptide 1 | 16 | L | Linear | Synthetic | NA | Conjugation with TAMRA | Amidation | NA | Fluorophore (TAMARA) | 23545289 |